Sign In

Tassos Gianakakos

Chief Executive Officer at MyoKardia

Professional Background

Tassos Gianakakos is a highly accomplished executive with a distinguished career in the biotechnology and pharmaceutical industries. His journey is a remarkable blend of education and experience in chemical engineering, economics, and business management, coupled with hands-on expertise in pharmaceutical development and business strategy. As the Chief Executive Officer at MyoKardia, Tassos has been pivotal in driving the company’s vision and operational excellence. Under his leadership, MyoKardia has made significant strides in the field of cardiovascular disease treatment, showcasing innovation and a commitment to improving patient outcomes.

Prior to his role at MyoKardia, Tassos served as the Senior Vice President and Chief Business Officer at MAP Pharmaceuticals, where he played a crucial role in shaping the company's business strategies and development initiatives. His responsibilities included overseeing the corporate and business development arms and leading the respiratory business unit, which helped MAP Pharmaceuticals enhance its market presence and drive growth. Tassos's strategic acumen was further demonstrated during his tenure at Codexis as SVP of Business Development, where he was integral in expanding the company’s pharmaceutical segment and positioning it for future success.

With a firm foundation in business development from his earlier role as Director of Business Development at Maxygen, he navigated complex partnerships and innovations that helped advance biotechnology solutions. Starting his professional journey as a process engineer at Merck, Tassos honed his technical expertise and understanding of pharmaceutical processes, laying a strong groundwork for his subsequent leadership roles.

Education and Achievements

Tassos Gianakakos’s academic credentials are as impressive as his professional achievements. He pursued his undergraduate studies at the prestigious Massachusetts Institute of Technology, where he earned dual Bachelor of Science degrees in Chemical Engineering and Economics. This unique combination of disciplines fostered a comprehensive understanding of both technical and business aspects of the pharmaceutical industry.

He further expanded his credentials by completing a Master of Business Administration (MBA) at the esteemed Harvard Business School. Here, he refined his leadership skills, strategic thinking, and business management capabilities, preparing him for executive roles in a competitive industry.

In addition to his business education, Tassos pursued a Master of Science in Biotechnology at Northwestern University. This advanced education provided him with deep insights into the latest biotechnological innovations, perfectly complementing his work in the pharmaceutical field.

Achievements

Throughout his career, Tassos Gianakakos has garnered a reputation for his strategic vision and ability to drive company growth through innovative initiatives. His contributions to MyoKardia have been particularly noteworthy, where he has overseen the development of groundbreaking therapies that address critical cardiovascular conditions.

A notable achievement in his career came during his time at MAP Pharmaceuticals, where he was instrumental in the development and commercialization of pioneering treatments which significantly improved patient care in respiratory health. Tassos's ability to navigate complex regulatory landscapes and foster strategic partnerships has led to successful product launches that have had lasting impacts on patients' lives.

Moreover, during his leadership at Codexis, Tassos played a key role in establishing groundbreaking collaborations that enhanced the company’s portfolio and solidified its reputation as a leader in biocatalysis used in pharmaceutical manufacturing.

His practical experience as a process engineer at Merck has enriched his leadership capabilities, giving him a solid understanding of the intricacies involved in pharmaceutical production and development.

In addition to his executive accomplishments, Tassos’s educational background is a testament to his commitment to continuous learning and professional development. His impressive journey from a chemical engineering and economics student at MIT to an MBA graduate from Harvard and MS in Biotechnology from Northwestern underscores his dedication to blending science and business to drive innovation.

Overall, Tassos Gianakakos exemplifies a dynamic leader whose multi-faceted education and extensive experience have made him a cornerstone of the biotechnology and pharmaceutical industries. His work continues to inspire many within the field, making him a sought-after innovator and strategist.

tags:[

Related Questions

What inspired Tassos Gianakakos to pursue a career in biotechnology and pharmaceuticals?
How has Tassos Gianakakos's education at MIT and Harvard Business School influenced his leadership style?
In what ways has Tassos Gianakakos contributed to the advancement of cardiovascular therapies at MyoKardia?
What are some specific challenges that Tassos Gianakakos faced while leading business development initiatives at MAP Pharmaceuticals?
How did Tassos Gianakakos leverage his experience at Merck to enhance his future roles in executive leadership?
Tassos Gianakakos
Add to my network

Location

San Francisco Bay Area